21 completed, 2 recruiting, 2 withdrawn, 1 active not recruiting. 12 Phase 4, 5 Phase 2, 4 Not applicable, 3 Phase 1, 3 Phase 3.
Follow Lispro: new trials by email Literature Review of Lispro trials Research Report on Lispro
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2) Insulin - Gestational Diabetes, Pregnancy Related | Not applicable | Recruiting | Thomas Jefferson University | 430 | 2024-09-01 | 2024-11-22 |
| Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes Insulin - Gestational Diabetes, Pregnancy Related | Not applicable | Recruiting | Thomas Jefferson University | 430 | 2024-09-01 | 2024-11-21 |
| Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec HDV-Lispro, Lispro - Diabetes Mellitus, Type 1 | Phase 2 | Completed | Diasome Pharmaceuticals | 227 | 2023-12-28 | 2026-07-31 |
| Automated Fully Closed-Loop Insulin Delivery in Type 1 Diabetes With Ultra-Rapid Lispro (ACOLYTE Study) Lispro - Diabetes Mellitus, Type 1 | Not applicable | Unknown | Manchester University NHS Foundation Trust | 26 | 2023-07-21 | 2023-10-31 |
| Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes Dapagliflozin, Glargine - Type2diabetes, Coronary Artery Disease | Phase 4 | Completed | Medanta, The Medicity, India | 250 | 2022-07-29 | 2023-10-19 |
| SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H) Sitagliptin 100mg, Glargine, Lispro - Type 2 Diabetes | Phase 4 | Completed | Hospital de Especialidades, Centro Medico Nacional "La Raza", Instituto Mexicano del Seguro Social | 76 | 2022-07-06 | 2023-09-26 |
| Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes Sliding Scale Insulin, Up-Titration of Home Insulin, Continuous Insulin Infusion - Diabetes Mellitus, Type 2, Preterm Birth | Phase 2 | Active not recruiting | University of Alabama at Birmingham | 120 | 2022-02-10 | 2026-07-14 |
| Remission Through Early Monitored Insulin Therapy - Duration Month Glargine, Lispro, Dexcom G6 - Type 2 Diabetes Mellitus | Phase 4 | Completed | Sandra Sobel | 10 | 2019-03-26 | 2021-10-12 |
| PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD inhaled human insulin, Insulin Lispro (Humalog U-100) - Safety and Tolerability | Phase 2 | Terminated | Dance Biopharm Inc. | 40 | 2018-02-06 | 2019-09-13 |
| Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy Exenatide, Lispro - Diabetic Nephropathies | Phase 4 | Completed | Nanfang Hospital, Southern Medical University | 92 | 2016-04-08 | 2020-03-09 |
| A Study of Lispro Formulations in Healthy Participants Lispro - Healthy Volunteers | Phase 1 | Completed | Eli Lilly and Company | 54 | 2014-12-01 | 2025-09-08 |
| Insulin Bolus Required for High Fat Foods in Type 1 Diabetes Lispro - Type 1 Diabetes | Not applicable | Completed | Joslin Diabetes Center | 10 | 2014-09-01 | 2017-04-26 |
| Safety and Efficacy Study of Correcting Hyperglycemia in Patients With Diabetes Having Out-patient Surgery Regular Insulin, Humalog - Type 1 Diabetes, Type 2 Diabetes | Phase 4 | Withdrawn | Emory University | 2013-10-01 | 2017-03-15 | |
| Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients Insulin protocol - Lymphoma, Diabetes Mellitus, Type 2 | Early Phase 1 | Completed | Washington University School of Medicine | 15 | 2013-09-01 | 2018-05-07 |
| CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM) Commercial Hylenex® recombinant (hyaluronidase human injection), Precommercial Hylenex recombinant (hyaluronidase human injection), Insulin lispro - Type 1 Diabetes Mellitus | Phase 4 | Completed | Halozyme Therapeutics | 456 | 2013-03-01 | 2018-11-07 |
| Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase Sham Injection, Recombinant human hyaluronidase PH20, Insulin aspart - Type 1 Diabetes Mellitus | Phase 4 | Completed | Halozyme Therapeutics | 25 | 2011-12-01 | 2019-02-26 |
| Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes Sitagliptin, glargine, lispro - Type 2 Diabetes Mellitus, Hospitalization | Phase 4 | Completed | Emory University | 90 | 2011-08-01 | 2018-12-07 |
| Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose LY2189265, Placebo, Insulin - Diabetes Mellitus, Type 2 | Phase 1 | Completed | Eli Lilly and Company | 32 | 2011-02-01 | 2014-10-07 |
| A Study of Postprandial Hyperglycemia in Participants With Type 2 Diabetes Lispro - Diabetes Mellitus, Type 2 | Phase 4 | Completed | Eli Lilly and Company | 72 | 2010-10-01 | 2014-04-03 |
| Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus Insulin lispro, Insulin aspart, Recombinant human hyaluronidase PH20 - Diabetes Mellitus, Type II | Phase 2 | Completed | Halozyme Therapeutics | 132 | 2010-08-01 | 2014-08-20 |
Showing 20 of 28. Sign in to see all of them.
Diabetes Mellitus, Type 2 (10) · Diabetes Mellitus, Type 1 (8) · Diabetes Mellitus (7) · Insulin Resistance (4) · Diabetes, Gestational (3) · Hyperglycemia (3) · Asthma (1) · Coronary Artery Disease (1) · Diabetic Nephropathies (1) · Lymphoma (1) · Premature Birth (1) · Pulmonary Disease, Chronic Obstructive (1) · Weight Gain (1)
Eli Lilly and Company (4) · Halozyme Therapeutics (4) · Biodel (2) · Emory University (2) · Sanofi (2) · Thomas Jefferson University (2) · Dance Biopharm Inc. (1) · Diasome Pharmaceuticals (1) · HealthPartners Institute (1) · Hospital de Especialidades, Centro Medico Nacional "La Raza", Instituto Mexicano del Seguro Social (1) · Joslin Diabetes Center (1) · Manchester University NHS Foundation Trust (1) · Medanta, The Medicity, India (1) · Nanfang Hospital, Southern Medical University (1) · Sandra Sobel (1)
United States (19) · India (2) · Argentina (1) · Australia (1) · Brazil (1) · Canada (1) · China (1) · Finland (1) · Germany (1) · Greece (1) · Hungary (1) · Mexico (1) · Netherlands (1) · Puerto Rico (1) · Romania (1)
Abraham Edgar Gracia-Ramos, MD, MSc (1) · Anna Roshal, MD (1) · Ashley N Battarbee, MD (1) · Carlson Karen, MD (1) · David A Rometo, MD (1) · Doug Green (1) · Douglas Muchmore, M.D. (1) · Douglas Muchmore, MD (1) · Garry Tobin, MD (1) · Guillermo Umpierrez, MD (1) · Howard Wolpert, MD (1) · Jing Fu (1)
PMID 15951574, PMID 19276235, PMID 19336625, PMID 19797280, PMID 19885269, PMID 19929994, PMID 20685497, PMID 21078733, PMID 21270182, PMID 21288502, PMID 23043164, PMID 23101951, PMID 23601190, PMID 23712381, PMID 23757434, PMID 23877988, PMID 24092662, PMID 25881510, PMID 26492541, PMID 26684274, PMID 26731258, PMID 27054932, PMID 27182178, PMID 27388474, PMID 29125636, PMID 29370047, PMID 31119456, PMID 31424780, PMID 31912605, PMID 33308193, PMID 34000260, PMID 35877134, PMID 37380728, PMID 38581842, PMID 39963952, PMID 8598962
K23HD103875 (1)